This is the ARVAC-Cecilia Grierson vaccine and it will be used as a booster against the COVID-19 variants circulating in the region.
✅ This vaccine, developed by the University of San Martín, scientific personnel from CONICET, and the Cassará laboratory, has proven to be safe and effective as a booster against COVID-19 in individuals over 18 years old.
At Grupo Sur, we are proud to share this news as we actively participated in a clinical trial to verify the safety of the ARVAC – Cecilia Grierson vaccine. 👉 For this purpose, we had the support of over 300 volunteers who, selflessly, contributed to national science.
🎗️ We continue to work with the firm conviction that more science means better health for everyone.
